JAK2 and myeloproliferative disorder: Subsequent cytogenetic analysis of myeloproliferative disorders did not detect any additional genetic alterations, including mutations in CALR, MPL, BCR-ABL1, or other JAK2 mutations, aside from JAK2 V617F.